The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
about
Hepatitis C avoidance in injection drug users: a typology of possible protective practicesIntimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CAImproving survey methods in sero-epidemiological studies of injecting drug users: a case example of two cross sectional surveys in Serbia and Montenegro.Unstable housing and hepatitis C incidence among injection drug users in a Canadian setting.Strategies to avoid opiate withdrawal: implications for HCV and HIV risksSelf reported health status, and health service contact, of illicit drug users aged 50 and over: a qualitative interview study in Merseyside, United KingdomHigher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort.High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillanceThe growing popularity of prescription opioid injection in downtown Montréal: new challenges for harm reduction.The common sense model applied to hepatitis C: a qualitative analysis of the impact of disease comparison and witnessed death on hepatitis C illness perceptionTaking care of themselves: how long-term injection drug users remain HIV and Hepatitis C freeBeliefs of Health Care Providers, Lay Health Care Providers and Lay Persons in Nigeria Regarding Hypertension. A Systematic Mixed Studies ReviewAn international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.More than just someone to inject drugs with: Injecting within primary injection partnerships.Housing instability among people who inject drugs: results from the Australian needle and syringe program surveyBarriers to practicing risk reduction strategies among people who inject drugs.Case-finding for hepatitis C in primary care: a mixed-methods service evaluation.The lived experience of hepatitis C and its treatment among injecting drug users: qualitative synthesis.Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco."SALOME gave my dignity back": the role of randomized heroin trials in transforming lives in the Downtown Eastside of Vancouver, Canada.Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs.Negotiating access to medical treatment and the making of patient citizenship: the case of hepatitis C treatment.High-Risk Geographic Mobility Patterns among Young Urban and Suburban Persons who Inject Drugs and their Injection Network Members.Barriers and facilitators towards fertility preservation care for cancer patients: a meta-synthesis.Hepatitis C in a new therapeutic era: Recontextualising the lived experience.Hepatitis C virus infection and related risk factors among injection drug users in Montenegro.Is disclosure a privilege? Race and disclosure patterns of hepatitis C.Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.Reinforced biographies among women living with hepatitis C.A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK.Evaluating a Dyadic Intervention on Risk Reduction Among People Who Inject Drugs“Doing the devil’s work”: Emotional labour and stigma in expanding Needle and Syringe Programs
P2860
Q28534592-27B59AEB-5F4F-48AB-947B-A48CD76659D9Q28543558-826560F2-FF44-4188-8787-ABF980B80FCCQ30486149-B0250C76-6470-44CF-9793-F7144B71AF41Q33488345-FA29CE56-AC4E-4033-81A5-AD115145E4BCQ33507211-5E772A2F-337A-4239-8925-3E3A93BBF8BBQ33509623-AA1DA53A-393B-4FCE-B6F0-79FEF57A6F3BQ33691250-19C6DD44-A0AD-4C97-9056-7029E2CC5D55Q35120376-5D12C06B-80C3-40E8-8590-4327F19B5F79Q35179636-22CE7CDD-4AAE-4EA3-8890-14FCFF8F5EDDQ35770129-C3A6BA96-5AE9-4620-BB30-A09E0C0F3ECEQ35772455-9A0B7BA6-CB1E-4919-A990-F25123043250Q36009332-B8C8C0D1-74B7-47C8-9A5C-9B89DBAE69F0Q36090175-FB24AAC8-A374-4A41-8344-250180BCC146Q36248999-0DF16F87-9812-4360-8296-DE02344F0212Q37067831-23DC0EF1-1D61-47C9-9A70-8BC576C01D75Q37149214-31EEA0F4-3316-423A-B016-EA183CF5E845Q37527057-2AF5EFBB-4F45-4CEB-864D-1B731D28FE19Q37582072-3EE6149F-F2CB-49BE-A08B-DA3DBB2F2C55Q37637059-5C44DC1E-71D2-414B-8BAD-CFE9A833F0D5Q37640117-9E478F17-0BBE-4B7B-BE6D-960D8D0F4B14Q38372109-08083BA8-5B7D-4874-A7DE-D5375F4D09B8Q38661825-A0E61CAB-5B86-4A3F-BAB6-FAA0D08A4659Q39050461-3043D40A-A0F5-4FB0-9536-EA2F8352331FQ39395685-94E05EFB-05B0-4DDA-B541-4E426D760290Q40056569-2D484761-D7CD-4FBC-80AC-4C4CC8A02509Q40202369-1694931B-4458-40EA-A488-922331F17071Q41928113-C5FD2FF7-9263-4746-B76D-DB7E719FF4F1Q42669477-B4F0A3E1-3C77-41B3-808B-D89145C666BBQ46435582-F63057E6-CBF4-4A32-B725-F0F6FD89F680Q49804072-262BAEDB-F99E-45B3-8ACE-971A3BACB27AQ52340382-D526DB37-C41C-4164-8D94-39808655E5CDQ55340444-69CBE753-AC60-401F-AB2E-EBEFB1FBB019Q57159214-1BF34BC0-4A8F-4063-A7AC-11ABA1DFFAF1Q58656414-E5757865-1607-469B-8986-8524D407B693
P2860
The social production of hepatitis C risk among injecting drug users: a qualitative synthesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The social production of hepat ...... sers: a qualitative synthesis.
@en
The social production of hepat ...... sers: a qualitative synthesis.
@nl
type
label
The social production of hepat ...... sers: a qualitative synthesis.
@en
The social production of hepat ...... sers: a qualitative synthesis.
@nl
prefLabel
The social production of hepat ...... sers: a qualitative synthesis.
@en
The social production of hepat ...... sers: a qualitative synthesis.
@nl
P1433
P1476
The social production of hepat ...... sers: a qualitative synthesis.
@en
P2093
Carla Treloar
Tim Rhodes
P304
P356
10.1111/J.1360-0443.2008.02306.X
P407
P577
2008-10-01T00:00:00Z